Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of bisoprolol transdermal patch for perioperative myocardial injury in patients undergoing non-cardiac surgery (Multi center Randomized Control Trial)

Next Previous
Trial Profile

Effects of bisoprolol transdermal patch for perioperative myocardial injury in patients undergoing non-cardiac surgery (Multi center Randomized Control Trial)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bisoprolol (Primary)
  • Indications Hypertension; Myocardial disorders
  • Focus Therapeutic Use
  • Acronyms MAMACARI

    • Most Recent Events

    • 12 Feb 2020 Results published in the Circulation Journal
    • 18 Nov 2019 Primary endpoint (prevalence of PMI defined as postoperative hs-cTnT 0.014 ng/mL and relative hs-cTnT change of 20%) has not been met, according to presented at the American Heart Association Scientific Sessions 2019
    • 18 Nov 2019 Results assessing efficacy of beta blocker patch versus oral used during operation for prevention of Perioperative myocardial injury in high risk patients were presented at the American Heart Association Scientific Sessions 2019
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top